- Home
- DUO vs CDIO Comparison
DUO vs CDIO Comparison
Compare DUO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- CDIO
- Stock Information
- Founded
- DUO 2011
- CDIO 2017
- Country
- DUO China
- CDIO United States
- Employees
- DUO N/A
- CDIO N/A
- Industry
- DUO Real Estate
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DUO Finance
- CDIO Health Care
- Exchange
- DUO Nasdaq
- CDIO Nasdaq
- Market Cap
- DUO 6.6M
- CDIO 6.4M
- IPO Year
- DUO 2019
- CDIO N/A
- Fundamental
- Price
- DUO $1.51
- CDIO $3.63
- Analyst Decision
- DUO
- CDIO Buy
- Analyst Count
- DUO 0
- CDIO 1
- Target Price
- DUO N/A
- CDIO $60.00
- AVG Volume (30 Days)
- DUO 161.9K
- CDIO 41.9K
- Earning Date
- DUO 08-29-2025
- CDIO 08-14-2025
- Dividend Yield
- DUO N/A
- CDIO N/A
- EPS Growth
- DUO N/A
- CDIO N/A
- EPS
- DUO 7.57
- CDIO N/A
- Revenue
- DUO $46,458,330.00
- CDIO $19,507.00
- Revenue This Year
- DUO N/A
- CDIO $1,434.82
- Revenue Next Year
- DUO N/A
- CDIO $4,661.91
- P/E Ratio
- DUO $0.20
- CDIO N/A
- Revenue Growth
- DUO 19.00
- CDIO N/A
- 52 Week Low
- DUO $1.48
- CDIO $3.22
- 52 Week High
- DUO $74.72
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- DUO 24.34
- CDIO 41.96
- Support Level
- DUO $1.70
- CDIO $3.58
- Resistance Level
- DUO $1.78
- CDIO $4.05
- Average True Range (ATR)
- DUO 0.12
- CDIO 0.33
- MACD
- DUO -0.00
- CDIO -0.01
- Stochastic Oscillator
- DUO 4.17
- CDIO 24.74
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.